Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B5c79c83acdfca435e5dcff3ab3c0da02> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B5c79c83acdfca435e5dcff3ab3c0da02 NCIT_P378 "NCI" @default.
- B5c79c83acdfca435e5dcff3ab3c0da02 type Axiom @default.
- B5c79c83acdfca435e5dcff3ab3c0da02 annotatedProperty IAO_0000115 @default.
- B5c79c83acdfca435e5dcff3ab3c0da02 annotatedSource NCIT_C156734 @default.
- B5c79c83acdfca435e5dcff3ab3c0da02 annotatedTarget "A monoclonal antibody directed against the human T-cell-expressed receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4; CTLA-4), with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, nurulimab targets and binds to CTLA-4 expressed on T-cells and inhibits the CTLA-4-mediated downregulation of T-cell activation. This leads to a cytotoxic T-lymphocyte (CTL)-mediated immune response against cancer cells. CTLA-4, an inhibitory receptor and member of the immunoglobulin superfamily (IgSF), plays a key role in the downregulation of the immune system." @default.